In breast cancer, CSCs express CD44+/CD24−/low/linage− stem cell-phenotype and are able to form mammospheres in suspension culture, differentiate into defined progenies, initiate and drive tumor growth in vivo [6,10,11]. Here, CD44 is linked to neoplasm.